- An
antiplatelet drug (antiaggregant), also
known as a
platelet agglutination inhibitor or
platelet aggregation inhibitor, is a
member of a
class of pharmaceuticals...
- Clopidogrel, sold
under the
brand name
Plavix among others, is an
antiplatelet medication used to
reduce the risk of
heart disease and
stroke in those...
-
related to
antiplatelet drugs and
thrombolytic drugs by mani****ting the
various pathways of
blood coagulation. Specifically,
antiplatelet drugs inhibit...
-
glycoprotein IIb/IIIa inhibitors, also GpIIb/IIIa inhibitors, is a
class of
antiplatelet agents.
Several GpIIb/IIIa
inhibitors exist:
abciximab (abcixifiban)...
- a
medication used to
reduce the risk of
thrombotic strokes. It is an
antiplatelet drug in the
thienopyridine family which is an
adenosine diphosphate (ADP)...
-
stroke were
treated with
antiplatelet therapy only.
Previous studies did not
identify a
clear benefit of PFO
closure over
antiplatelet therapy in reducing...
- 50 years. However,
several studies have
shown that
aspirin and
other antiplatelets are
highly effective in
secondary prevention after stroke or transient...
-
Adenosine diphosphate (ADP)
receptor inhibitors are a drug
class of
antiplatelet agents, used in the
treatment of
acute coronary syndrome (ACS) or in preventive...
- has not been
found to be
useful in
secondary stroke prevention. The
antiplatelet medications,
aspirin and clopidogrel, are both
recommended for secondary...
-
duration of dual-
antiplatelet therapy after stent implantation: a pre-specified
analysis from the
PRODIGY (Prolonging Dual-
Antiplatelet Treatment After...
